Date: 2011-11-07
Type of information: R&D agreement
Compound: therapeutic monoclonal antibodies
Company: Antitope (UK) Therapure Biopharma (Canada)
Therapeutic area:
Type agreement: R&D
Action mechanism:
Disease:
Details: Antitope has announced a research agreement with Therapure Biopharma for the generation of therapeutic monoclonal antibodies. Under theagreement, Antitope will apply its proprietary Composite Human Antibody™ technology for the generation of humanized antibodies for a range of clinical indications.
Financial terms:
Latest news:
